Tag: testing

A doctor may perform one or more tests to diagnose atrial fibrillation (A-fib). The doctor will look for signs of A-fib as well as any underlying conditions that might be causing arrhythmia and possible complications. Sometimes a doctor will refer someone to a cardiologist, who is a specialist in heart disease. In this article, we

WWII codebreaker Alan Turing’s mathematical genius could create better detection tests for cancer and other fatal diseases, experts say Turing’s ‘weight of evidence’ theory may assist in better diagnostic tools  It could also personalise treatment to maximise a person’s chances of recovery Currently, modern-day testing relies on techniques developed in the mid 1980s  Alan Turing’s

A new clinical trial at Emory University and 45 other sites around the U.S. will test a combination of vitamins and steroids in patients diagnosed with sepsis. Sepsis is caused by the body’s overwhelming and life-threatening response to infection that can lead to tissue damage, organ failure and death. According to sepsis researchers, sepsis can

Prostate cancer is the second most common cancer in American men. But black men bear a disproportionate burden of its effects. It’s more common—and more than twice as deadly—among black men compared to their white counterparts. Yet the United States Preventive Services Task Force (USPSTF) recommendations for prostate cancer screening do not differentiate for race,

NHS will become the first health service to use routine genetic testing in a move that will ‘transform patients’ lives’ Genomic Medicine Service will be used on people at risk of 22 genetic diseases Hopes it will boost early diagnoses and improve preventative care Treatment will shift from being ‘one size fits all’ to a

Routine testing for prostate cancer is not recommended for most men because the benefit is small and uncertain and there are clear harms, say a panel of international experts in The BMJ today. But they acknowledge that some men, such as those with a family history of prostate cancer, may be more likely to consider

A new community-based model to treat HIV and other health conditions in rural East Africa led to 20 percent fewer HIV deaths, reduced the incidence of HIV and tuberculosis (TB), and improved control of hypertension and diabetes, according to results presented today at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam. The results are

WEDNESDAY, July 11, 2018 — The attending surgeon is associated with variation in the receipt of genetic testing after breast cancer diagnosis, according to a study published online July 3 in JAMA Surgery. Steven J. Katz, M.D., M.P.H., from the University of Michigan Medical School in Ann Arbor, and colleagues examined the correlation of attending

Advanced algorithms working from large chemical databases can predict a new chemical’s toxicity better than standard animal tests, suggests a study led by scientists at Johns Hopkins Bloomberg School of Public Health. The researchers, in the study that appears in the journal Toxicological Sciences on July 11, mined a large database of known chemicals they

For many women diagnosed with breast cancer, genetic testing can offer important information that might guide treatment choices. But studies have shown that only about half of women who could benefit receive genetic testing. A new study finds that surgeons are a key influence. “The surge of genetic testing in cancer care is a major

A recent study by sensory researchers at Kansas State University’s Olathe campus finds that emojis are a viable alternative to words when it comes to accurately measuring how kids feel about food, products and other experiences. The results appear in the study, “The emoji scale: A facial scale for the 21st century,” which was published

Women with an aggressive form of breast cancer who have faults in their BRCA genes do much better on chemotherapy drug carboplatin than standard treatment, a major clinical trial reports. Researchers found that women with advanced ‘triple-negative’ breast cancer who had inherited a BRCA mutation were twice as likely to benefit from carboplatin as docetaxel,

On-site testing of ‘party drug’ pills could reduce the harms caused by drug use and potentially save lives, according to an independent review of Australia’s National Drug Strategy, published in the open access Harm Reduction Journal. Dr Andrew Groves at Deakin University, Australia, examines evidence in support of pill testing to reduce fatalities caused by